Patents by Inventor Xianwei WANG

Xianwei WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240151982
    Abstract: An electronic device may have a display system. The display system may include a waveguide, an input coupler, and a surface relief grating (SRG) structure. The SRG structure may be formed from a high-index material that includes titanium dioxide nanoparticles. To increase the refractive index of the high-index material, the ratio of the size of the nanoparticle core to the size of the capping layer may be increased. The high-index material may also include nanoparticles of different sizes to increase the packing density of the nanoparticles. The SRG structure may be depth modulated in a lateral direction to maximize efficiency. The SRG structure may include slanted ridges covered by an encapsulant. The SRG structure may include a blazed grating with ridges that are covered by a coating and encapsulated by an encapsulant.
    Type: Application
    Filed: January 8, 2024
    Publication date: May 9, 2024
    Inventors: Yifei Wang, Xiaoyong Fu, Wencong Zhu, Xianwei Zhao, Brandon Born
  • Publication number: 20240138546
    Abstract: Provided are various embodiments of a fastening assembly and wearable mount as well as methods, devices, components, and assemblies associated therewith. An example fastening assembly includes a trigger assembly having an actuator configured to be operated by a user and a housing comprising a housing connection portion. The housing may receive the actuator. The fastening assembly may further include a connector configured to engage the housing connection portion.
    Type: Application
    Filed: October 9, 2023
    Publication date: May 2, 2024
    Inventors: Menglong GAO, Yuyan WANG, Xianwei YAN, Fei ZHAO, Yuefeng MO, Rui HOU
  • Publication number: 20240147649
    Abstract: An inverter and an integrated platform having the same are provided. The inverter includes a cabinet having a cabinet door; an inverter body arranged in the cabinet; and a heat exchanger arranged on an outer side of the cabinet, where the inverter body has an alternating-current side, and the cabinet door is arranged on the alternating-current side or an opposite side of the alternating-current side of the inverter body.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 2, 2024
    Applicant: Sungrow Power Supply Co., Ltd.
    Inventors: Xiaohu Wang, Qiyao Zhu, Xianwei Zhang, Jun Tan
  • Publication number: 20240093554
    Abstract: Provided is a two-stage reverse-torque bent screw orientation tool. An existing bent screw orientation technology has the technical problems of large friction resistance, difficult control of a borehole track, a low drilling speed and the like, and restricts economic, safe and long-acting development of oil and gas. In order to solve the above problems, the two-stage reverse-torque bent screw orientation tool is invented and composed of a first-stage clutch mechanism and a second-stage clutch mechanism, and the first-stage clutch mechanism and the second-stage clutch mechanism are both composed of a battery, a battery compartment, a pressure sensor, an electromagnetic valve, a body, a plug, a piston, an outer tooth cylinder, an inner tooth cylinder, a transmission cylinder, a connecting cylinder, a bearing, a limiting cylinder, a lower joint, a thrust bearing, a battery compartment, a circuit board, a cover plate and the like.
    Type: Application
    Filed: September 8, 2023
    Publication date: March 21, 2024
    Inventors: Qingyou LIU, Jianguo ZHAO, Guorong WANG, Haiyan ZHU, Xuecheng DONG, Xingming WANG, Xu LUO, Yingju PEI, Xianwei DAI
  • Publication number: 20240091172
    Abstract: A drug for antagonizing the replication of porcine reproductive and respiratory syndrome virus (PRRSV) and an application thereof. By using a viral infection test, a drug which antagonizes PRRSV—xanthohumol—is discovered for the first time from among a natural drug library of 386 plant sources. Xanthohumol can effectively inhibit PRRSV replication on both Marc-145 and PAM cells. Five xanthohumol derivatives having different molecular structures are artificially synthesized, and it is discovered that a derivative Xn-4 has the strongest inhibitory effect on virus replication in vitro. Test results of artificial infection and drug therapy in piglets show that the Xn-4 can effectively inhibit PRRSV viremia, relieve clinical symptoms of infected pigs, and significantly reduce lung inflammation and pathological damage.
    Type: Application
    Filed: June 3, 2020
    Publication date: March 21, 2024
    Applicant: NANJING AGRICULTURAL UNIVERSITY
    Inventors: Ping JIANG, Xuewei LIU, Juan BAI, Junren ZHANG, Xianwei WANG, Yufeng LI